Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Michael O'Riordan

August 10, 2023

News Daily News

Who Gets a Heart Transplant? Ranking Process Must Evolve, Again

Yael L. Maxwell

April 17, 2023

News Daily News

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Shelley Wood

March 31, 2023

News Daily News

Second Recall in Less Than 2 Months for Cardiosave IABPs

L.A. McKeown

March 17, 2023

News Daily News

New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump

Shelley Wood

January 25, 2023

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

Shelley Wood

August 02, 2021

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

Caitlin E. Cox

June 07, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Opinion Fellow Talk

Hemodynamics Galore: What I Learned at the C3 Summit

Tiffany Patterson, MBBS

July 27, 2016

Advertisement

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Who Gets a Heart Transplant? Ranking Process Must Evolve, Again

Another Recall Warns of Unheralded Shutdowns With Cardiosave IABPs

Second Recall in Less Than 2 Months for Cardiosave IABPs

New IABP Recall: Balloon Catheter Damage Might Cause Bleeding Into Pump

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

TCTMD’s Top 10 Most Popular Stories for July 2022

April 2022 News Roundup

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

TCTMD’s Top 10 Most Popular Stories for July 2021

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

TCTMD’s Top 10 Most Popular Stories for June 2017

Hemodynamics Galore: What I Learned at the C3 Summit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content